Evidence map›Paper›PMID 22253471›Full record

ArticleJournal of lipid research2012

Defective lipid remodeling of GPI anchors in peroxisomal disorders, Zellweger syndrome, and rhizomelic chondrodysplasia punctata.

Noriyuki Kanzawa, Nobuyuki Shimozawa, Ronald J A Wanders, Kazutaka Ikeda, Yoshiko Murakami, Hans R Waterham, Satoru Mukai, Morihisa Fujita, Yusuke Maeda, Ryo Taguchi and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Organelle interplay-peroxisome interactions in health and disease.Journal of inherited metabolic disease · 2020
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. The peroxisome: an update on mysteries.Histochemistry and cell biology · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Noriyuki KanzawaDepartment of Immunoregulation, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan.
Nobuyuki Shimozawa
Ronald J A Wanders
Kazutaka Ikeda
Yoshiko Murakami
Hans R Waterham
Satoru Mukai
Morihisa Fujita
Yusuke Maeda
Ryo Taguchi
Yukio Fujiki
Taroh Kinoshita
Osaka University · JPKyushu University · JPThe University of Tokyo · JPAcademic Medical Center · NLGifu University · JPUniversity of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many cell surface proteins in mammalian cells are anchored to the plasma membrane via glycosylphosphatidylinositol (GPI). The predominant form of mammalian GPI contains 1-alkyl-2-acyl phosphatidylinositol (PI), which is generated by lipid remodeling from diacyl PI. The conversion of diacyl PI to 1-alkyl-2-acyl PI occurs in the ER at the third intermediate in the GPI biosynthetic pathway. This lipid remodeling requires the alkyl-phospholipid biosynthetic pathway in peroxisome. Indeed, cells defective in dihydroxyacetone phosphate acyltransferase (DHAP-AT) or alkyl-DHAP synthase express only the diacyl form of GPI-anchored proteins. A defect in the alkyl-phospholipid biosynthetic pathway causes a peroxisomal disorder, rhizomelic chondrodysplasia punctata (RCDP), and defective biogenesis of peroxisomes causes Zellweger syndrome, both of which are lethal genetic diseases with multiple clinical phenotypes such as psychomotor defects, mental retardation, and skeletal abnormalities. Here, we report that GPI lipid remodeling is defective in cells from patients with Zellweger syndrome having mutations in the peroxisomal biogenesis factors PEX5, PEX16, and PEX19 and in cells from patients with RCDP types 1, 2, and 3 caused by mutations in PEX7, DHAP-AT, and alkyl-DHAP synthase, respectively. Absence of the 1-alkyl-2-acyl form of GPI-anchored proteins might account for some of the complex phenotypes of these two major peroxisomal disorders.

Indexed as

AcyltransferasesAlkyl and Aryl TransferasesAnimalsCell Line, TransformedCHO CellsChondrodysplasia Punctata, RhizomelicCricetinaeFibroblastsGlycosylphosphatidylinositolsHumansMembrane ProteinsMutationPeroxisomal Targeting Signal 2 ReceptorPeroxisomesReceptors, Cytoplasmic and NuclearTransfectionAcyltransferasesAlkyl and Aryl Transferasesalkylglycerone-phosphate synthaseglycerone-phosphate O-acyltransferaseGlycosylphosphatidylinositolsMembrane ProteinsPeroxisomal Targeting Signal 2 ReceptorPEX16 protein, humanPEX19 protein, humanPEX7 protein, humanReceptors, Cytoplasmic and Nuclear

Identifiers

PMID22253471
PMCPMC3307642
OpenAlexW2155134353

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.